MAP3K2 and cancer: Although the known targets of miR-186 have not been completely clarified, research has found that miR-186 targets mitogen-activated protein kinase kinase kinase 2 (MAP3K2) (23), protein phosphatase PPM1B (24), and Jagged1 (25) to regulate cancer cell proliferation and metastasis.